MYASTHENIA GRAVIS, GENERALIZED
Clinical trials for MYASTHENIA GRAVIS, GENERALIZED explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS, GENERALIZED trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, GENERALIZED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to tame muscle weakness in myasthenia gravis
Disease control Recruiting nowThis study tests an experimental drug called povetacicept in adults with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see if the drug safely reduces harmful immune proteins. About 30 participants will receive either the drug or a placebo,…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New study tracks Ravulizumab's impact on daily life in myasthenia gravis
Disease control Recruiting nowThis observational study follows 50 adults with generalized myasthenia gravis who are new to complement inhibitors and are receiving ravulizumab (Ultomiris) in Poland. Researchers will track changes in daily living activities and other symptoms over time. The goal is to see how w…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aritinercept aims to tame myasthenia gravis symptoms
Disease control Recruiting nowThis study tests a new drug, aritinercept, in 81 adults with generalized myasthenia gravis. The drug works by blocking two immune signals (BAFF and APRIL) to reduce disease activity. Researchers are checking if it is safe and if it improves daily living activities compared to a p…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE1, PHASE2 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug may help elderly MG patients ditch harmful steroids
Disease control Recruiting nowThis study looks at whether efgartigimod, a drug that lowers harmful antibodies, can help elderly patients with generalized myasthenia gravis reduce their steroid use. Steroids often cause serious side effects in older adults. The study will follow 50 patients for 12 months to se…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Massive study aims to unlock secrets of brain inflammation diseases
Knowledge-focused Recruiting nowThis research study collects health information from 10,000 people with brain inflammation conditions like Long COVID, ME/CFS, and autoimmune diseases. Participants use a smartphone app to share symptoms, health history, and wearable data. The goal is to find disease subtypes and…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Sponsor: Brain Inflammation Collaborative • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC